Q32 Bio (QTTB) Profit After Tax (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -113.17% |
| Dec 31, 2025 | 880.89% |
| Sep 30, 2025 | 22.13% |
| Jun 30, 2025 | 13.98% |
| Mar 31, 2025 | 22.26% |
| Dec 31, 2024 | 19.36% |
| Sep 30, 2024 | -3.63% |
| Jun 30, 2024 | -1,749.95% |
| Mar 31, 2024 | 103.80% |
| Dec 31, 2023 | -92.91% |
| Sep 30, 2023 | -141.62% |
| Jun 30, 2023 | 15.08% |
| Mar 31, 2023 | 80.06% |
| Dec 31, 2022 | -1.69% |
| Sep 30, 2022 | -15.94% |
| Jun 30, 2022 | -131.58% |
| Mar 31, 2022 | 374.26% |
| Dec 31, 2021 | -9.72% |
| Sep 30, 2021 | -0.35% |
| Jun 30, 2021 | -2,742.50% |
| Mar 31, 2021 | 96.40% |
| Dec 31, 2020 | -5.52% |
| Sep 30, 2020 | 20.11% |
| Jun 30, 2020 | -0.03% |
| Mar 31, 2020 | -46.20% |
| Dec 31, 2019 | 18.43% |
| Sep 30, 2019 | -12.78% |
| Jun 30, 2019 | -10.14% |
| Mar 31, 2019 | -26.97% |
| Dec 31, 2018 | -32.78% |
| Sep 30, 2018 | -13.86% |
| Jun 30, 2018 | -21.62% |
| Mar 31, 2018 | 14.19% |
| Dec 31, 2017 | -82.39% |
| Sep 30, 2017 | -8.74% |
| Jun 30, 2017 | -8.06% |